BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 9290601)

  • 1. The metabolic crisis: a diagnostic challenge [editoria; comment].
    Bove KE
    J Pediatr; 1997 Aug; 131(2):181-2. PubMed ID: 9290601
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolic crisis in an infant--is the problem in the mitochondria?].
    Tyni T; Pihko H
    Duodecim; 2002; 118(13):1331-9. PubMed ID: 12239878
    [No Abstract]   [Full Text] [Related]  

  • 3. Sudden infant death syndrome and multiple acyl-coenzyme A dehydrogenase deficiency, ethylmalonic-adipic aciduria, or systemic carnitine deficiency.
    Harpey JP; Charpentier C; Coudé M; Divry P; Paturneau-Jouas M
    J Pediatr; 1987 Jun; 110(6):881-4. PubMed ID: 3585604
    [No Abstract]   [Full Text] [Related]  

  • 4. Medium chain acyl-coenzyme A dehydrogenase deficiency.
    Bennett MJ; Hale DE
    N J Med; 1992 Sep; 89(9):675-8. PubMed ID: 1436730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carnitine deficiency in inborn errors of metabolism].
    Sela BA; Lerman-Sagie T; Berkovitz M
    Harefuah; 1997 Nov; 133(10):419-23, 504. PubMed ID: 9418309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fate of orally ingested 3-phenylpropionic acid.
    Duran M; van Vossen R; Bruinvis L; Ketting D; Dorland L; de Klerk JB
    Prog Clin Biol Res; 1990; 321():419-26. PubMed ID: 2326303
    [No Abstract]   [Full Text] [Related]  

  • 7. Medium chain acyl coenzyme A dehydrogenase (MCAD) deficiency: the case for screening all newborns.
    Alluri VN; Mulvihill JJ
    J Okla State Med Assoc; 2002 May; 95(5):326-8. PubMed ID: 12043106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCAD deficiency. Acylcarnitines (AC) by tandem mass spectrometry (MS-MS) are useful to monitor dietary treatment.
    Abdenur JE; Chamoles NA; Specola N; Schenone AB; Jorge L; Guinle A; Bernard CI; Levandowskiy V; Lavorgna S
    Adv Exp Med Biol; 1999; 466():353-63. PubMed ID: 10709663
    [No Abstract]   [Full Text] [Related]  

  • 9. Medicine. Fast technology drives new world of newborn screening.
    Marshall E
    Science; 2001 Dec; 294(5550):2272-4. PubMed ID: 11743177
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-mortem recognition of inherited metabolic disorders from specific acylcarnitines in tissue in cases of sudden infant death.
    Roe CR; Millington DS; Maltby DA; Wellman RB
    Lancet; 1987 Feb; 1(8531):512. PubMed ID: 2881073
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic tests for acyl-coenzyme A dehydrogenase deficiency.
    Elpeleg ON
    J Pediatr; 1992 Oct; 121(4):667-8. PubMed ID: 1403411
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medium chain Acyl-Coa Dehydrogenase deficiency. A diagnostic challenge for clinicians and laboratory].
    Heinonen OJ; Iitiä A; Irjala K; Pulkki K
    Duodecim; 1996; 112(1):35-41. PubMed ID: 10590599
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal screening for inborn errors of metabolism.
    Morris AA
    Indian Pediatr; 2000 Dec; 37(12):1303-6. PubMed ID: 11119331
    [No Abstract]   [Full Text] [Related]  

  • 14. [Application of tandem mass spectrometry on the diagnosis of fatty acid oxidation disorders].
    Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Zhang YJ; Gu XF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):692-5. PubMed ID: 18067086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic defect in carnitine transport causing primary carnitine deficiency.
    Stanley CA; Treem WR; Hale DE; Coates PM
    Prog Clin Biol Res; 1990; 321():457-64. PubMed ID: 2326306
    [No Abstract]   [Full Text] [Related]  

  • 16. Neonatal screening for medium chain acyl-CoA deficiency: high incidence in Lower Saxony (northern Germany).
    Sander S; Janzen N; Janetzky B; Scholl S; Steuerwald U; Schäfer J; Sander J
    Eur J Pediatr; 2001 May; 160(5):318-9. PubMed ID: 11388605
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for inherited metabolic disease in newborn infants using tandem mass spectrometry.
    Leonard JV; Dezateux C
    BMJ; 2002 Jan; 324(7328):4-5. PubMed ID: 11777783
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurological diseases in disorders of organic acids.
    Marsden DL; Nyhan WL
    Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):349-54. PubMed ID: 1623263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders.
    Millington DS; Terada N; Chace DH; Chen YT; Ding JH; Kodo N; Roe CR
    Prog Clin Biol Res; 1992; 375():339-54. PubMed ID: 1438380
    [No Abstract]   [Full Text] [Related]  

  • 20. Public health explores expanding newborn screening for cystic fibrosis, congenital adrenal hyperplasia, and medium-chain acyl coenzyme A dehydrogenase deficiency (MCAD).
    Rhoades E; King P
    J Okla State Med Assoc; 2001 Apr; 94(4):129-32. PubMed ID: 11392180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.